Physician
Gastroenterology
Dr. Hugo E. Vargas, MD
|
|
Give Review
Hugo Vargas is an expert in the field of Gastroenterology. He attended Drexel University College of Medicine. He received 15 awards: "Fellow (FAASLD)", "AASLD Fellow", "Outstanding Program Director of the Year", "Top 10 % Reviewer 2008", "Fellow (AGAF)", "Fellow (FACP)", "Outstanding Reviewer Award", "Educator of the Year Award for Research", "Young Investigator Award for the World Congress of Gastroenterology", "Outstanding Medical Resident of the Year", "Chairman's Invitational Honors Program in Medicine", "Honors Award, Anatomy, Medicine, Ambulatory Care & Dermatology", "Summer Research Award", "Honors Award, Department of Physiology and Biophysics" and "Fellow (FACG)". Hugo Vargas has written publications. He has 98 publications published with PubMed. The lastest paper is: 'The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1.' Hugo Vargas is registered with Medicare.
Publications
- Docetaxel Induced Sclerosing Cholangitis.
- Effectiveness of Simeprevir plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients with HCV Genotype 1 Infection.
- Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates.
- Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation.
- Magnetic resonance elastography (MRE) in assessing hepatic fibrosis: performance in a cohort of patients with histological data.
- An Interferon-free Antiviral Regimen for HCV after Liver Transplantation.
- Nonsteroidal anti-inflammatory drug-induced hepatoxicity.
- Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat Hepatitis C genotype 1 after liver transplantation.
- Portal Vein Thrombosis in Patients with End Stage Liver Disease Awaiting Liver Transplantation: Outcome of Anticoagulation.
- Endoscopic treatment of anastomotic Biliary strictures after living donor liver transplantation: outcomes after maximal stent therapy.
- A randomized multicenter study comparing steroid-free and standard immunosuppression for liver transplant recipients with chronic Hepatitis C.
- Six-minute walk distance predicts mortality in liver transplant candidates.
- Treatment of Hepatitis C in renal transplantation candidates: a single-center experience.
- An unusual occurrence of giant cell Hepatitis.
- Natural history of post-liver transplantation Hepatitis C: A review of factors that may influence its course.
- Liver transplantation: from Child to MELD.
- MR imaging of hypervascular liver masses: a review of current techniques.
- Severe hepatotoxicity caused by a methasteron-containing performance-enhancing supplement.
- Treatment of Hepatitis C in liver transplant recipients.
- The transplantation candidate with alcohol misuse: the selection minefield.
- Persistence of Hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy.
- Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in Hepatitis C patients treated with combination antiviral therapy.
- Inpatient admissions for drug-induced liver injury: results from a single center.
- Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation.
- Living donor liver transplantation in polycystic liver Disease.
- Esophageal capsule endoscopy for screening and surveillance of Esophageal varices in patients with portal hypertension.
- New frontiers in small-bowel imaging: the expanding technology of capsule endoscopy and its impact in clinical gastroenterology.
- Transient left ventricular apical ballooning Syndrome (Takotsubo cardiomyopathy) following orthotopic liver transplantation.
- Endoscopic treatment of anastomotic Biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapy.
- Macro-aspartate aminotransferase and monoclonal gammopathy: a review of two cases.
- Pegylated interferon and ribavirin failures: is retreatment an option?
- Should antiHepatitis B virus core positive or antiHepatitis C virus core positive subjects be accepted as organ donors for liver transplantation?
- Vitamin A toxicity: when one a day doesn't keep the doctor away.
- A difficult case of primary sclerosing cholangitis.
- Liver transplantation in the MELD era: a single-center experience.
- Portal hypertension due to a splenic arteriovenous fistula: a case report.
- Living donor liver transplantation for hepatitis C-related Cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation re...
- Hepatic B-cell non-Hodgkin''s lymphoma of MALT type in the liver explant of a patient with chronic Hepatitis C infection.
- Artificial neural network and tissue genotyping of hepatocellular carcinoma in liver-transplant recipients: prediction of recurrence.
- Management of Hepatitis C virus infection in the setting of liver transplantation.
- Hepatitis C virus antiviral therapy in patients with Cirrhosis.
- Hepatitis C virus infection with hepatocellular carcinoma: not a controversial indication for liver transplantation.
- Primary biliary cirrhosis and Systemic amyloidosis, a new association.
- Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.
- Hepatopulmonary Syndrome after living donor liver transplantation and deceased donor liver transplantation: a single-center experience.
- Controversies in the management of hepatitis C patients with advanced fibrosis and Cirrhosis.
- Treatment of recurrent Hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series.
- Hepatitis C virus recurrence in living donor liver transplant recipients.
- Hepatic steatosis in Hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?
- Liver transplantation for hepatocellular carcinoma: the MELD impact.
- Progression of liver fibrosis in patients with chronic Hepatitis C after orthotopic liver transplantation.
- Controversies in the management of Hepatitis C virus infection after liver transplantation.
- The use of Hepatitis C-infected grafts in liver transplantation.
- Hepatitis C virus quasispecies: misunderstood and mistreated?
- The use of virologically compromised organs in liver transplantation.
- Detection of Hepatitis C virus sequences in brain tissue obtained in recurrent Hepatitis C after liver transplantation.
- Hepatitis C: magnitude of the problem.
- Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related Cirrhosis.
- A concise update on the status of liver transplantation for Hepatitis B virus: the challenges in 2002.
- New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database.
- Short-term cardiac and noncardiac mortality following liver transplantation.
- Regional variations in peer reviewed liver allocation under the MELD System.
- Virologically compromised donor grafts in liver transplantation.
- The origin of Hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus.
- Changes in Hepatitis C virus population in serum and peripheral blood mononuclear cells in chronically infected patients receiving liver graft from infected donors.
- Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome.
- Hepatitis G virus coinfection in Hepatitis C virus-infected liver transplant recipients.
- Hepatitis G virus infection in American patients with cryptogenic Cirrhosis: no evidence for liver replication.
- Detection of Hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation.
- Hepatitis C virus in peripheral blood mononuclear cells from a chronically infected patient receiving liver graft from infected donor.
- Clinical and virologic outcomes of Hepatitis B and C viral coinfection after liver transplantation: effect of viral Hepatitis D.
- Search for Hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in var...
- The presence of active Hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1.
- Hepatitis C virus negative strand RNA is not detected in peripheral blood mononuclear cells and viral sequences are identical to those in serum: a case against extrahe...
- Outcome of liver transplantation in Hepatitis C virus-infected patients who received Hepatitis C virus-infected grafts.
- The influence of Hepatitis C virus genotypes on the outcome of liver transplantation.
- A randomized, double-blind, placebo-controlled trial of interferon-alpha and amantadine versus interferon-alpha alone in the treatment of patients with chronic hepatit...
- Dynamic behavior of Hepatitis C virus in chronically infected patients receiving liver graft from infected donors.
- Clinical significance of elevated alpha-fetoprotein in adults and children.
- Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication.
- Retransplantation for Hepatitis C: results of a U.S. multicenter retransplant study.
- Quality of life in long-term survivors after liver transplantation: impact of recurrent viral Hepatitis C virus Hepatitis.
- Comparison of Hepatitis B virus core promoter sequences in peripheral blood mononuclear cells and serum from patients with Hepatitis B.
- Exposure of Hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/o...
- Lack of evidence for GB virus C/Hepatitis G virus replication in peripheral blood mononuclear cells.
- Lack of evidence for Hepatitis G virus replication in the livers of patients coinfected with Hepatitis C and G viruses.
- Late-onset renal failure after liver transplantation: role of posttransplant alcohol use.
- The real danger of lamivudine-resistant Hepatitis B virus infection in the immunocompromised host.
- Association between Hepatitis B virus core promoter rearrangements and hepatocellular carcinoma.
- Natural history of Hepatitis C and outcomes following liver transplantation.
- Amplification and fusion of long fragments of Hepatitis C virus genome.
- Distribution of infecting hepatitis C virus genotypes in end-stage liver Disease patients at a large American transplantation center.
- Detection of Hepatitis G virus replication sites by using highly strand-specific Tth-based reverse transcriptase PCR.
- Detection and analysis of Hepatitis C virus sequences in cerebrospinal fluid.
- Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous System: evidence of replication.
- Isolated Intestinal versus composite visceral allografts: causes of graft failure.
- Selection of different 5'' untranslated region Hepatitis C virus variants during post-transfusion and post-transplantation infection.
Schools
Hahnemann University
University Utah Hosps
University Of Pittsburgh
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
Awards
- Fellow (FAASLD)
- AASLD Fellow
- Outstanding Program Director of the Year
- Top 10 % Reviewer 2008
- Fellow (AGAF)
- Fellow (FACP)
- Outstanding Reviewer Award
- Educator of the Year Award for Research
- Young Investigator Award for the World Congress of Gastroenterology
- Outstanding Medical Resident of the Year
- Chairman's Invitational Honors Program in Medicine
- Honors Award, Anatomy, Medicine, Ambulatory Care & Dermatology
- Summer Research Award
- Honors Award, Department of Physiology and Biophysics
- Fellow (FACG)
Education
-
University of Pittsburgh Medical Center -
University of Utah -
Drexel University College of Medicine
Hospital
-
Mayo Clinic - Phoenix/Scottsdale, Arizona
Drug Facts
| NPI NUMBER | 1730164260 | |
| NPPES Provider LastName | VARGAS | |
| NPPES Provider FirstName | HUGO | |
| NPPES Provider ZIPCode | 850544502 | |
| NPPES Provider State | AZ | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 251.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 17.0 | |
| Percent Opioid Claims | 6.77 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730164260 |
| Last Name Of The Provider | VARGAS |
| First Name Of The Provider | HUGO |
| View All |
Similar Doctors
|
|
Dr. Yamini Subbiah, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard A. Manch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rodney A. Engel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. M P. Lance, MD |
|
|
Dr. Joseph D. Motto Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James D. Panetta Jr., DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alberto X. Ramos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Tessler, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mansur A. Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amitkumar Patel, MD |
|
|
Dr. Jyotsna Ravi, MD
This Doctor is OpenDoctor Recommended.
|